Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Eli Lilly, Junshi collaborate to develop antibody therapies for Covid-19 disease

pharmaceutical-business-reviewMay 05, 2020

Tag: Eli Lilly , Junshi Biosciences , COVID-19 , antibody therapies , SARS-CoV-2

PharmaSources Customer Service